Dyazide and Hyporeflexia - a phase IV clinical study of FDA data

Summary:

Hyporeflexia is reported as a side effect among people who take Dyazide (hydrochlorothiazide; triamterene), especially for people who are female, 40-49 old, also take Lipitor, and have Pain.

The phase IV clinical study analyzes which people have Hyporeflexia when taking Dyazide. It is created by eHealthMe based on reports of 11,105 people who have side effects when taking Dyazide from the FDA, and is updated regularly.

What is Dyazide?

Dyazide has active ingredients of hydrochlorothiazide; triamterene. It is often used in high blood pressure. eHealthMe is studying from 11,506 Dyazide users. Check the latest studies of Dyazide.

What is Hyporeflexia?

Hyporeflexia (a condition of below normal or absent reflexes) is found to be associated with 448 drugs and 593 conditions by eHealthMe. Check the latest studies of Hyporeflexia.

On Jul, 18, 2026

11,105 people reported to have side effects when taking Dyazide.
Among them, 18 people (0.16%) have Hyporeflexia.

Among these 18 people:

What is the gender of people who have Hyporeflexia when taking Dyazide? *

female: 88.89 %
male: 11.11 %

What is the age of people who have Hyporeflexia when taking Dyazide? *

What are other drugs people take besides Dyazide? *

What are other side effects people have besides Hyporeflexia? *

Fatigue (feeling of tiredness): 14 people, 77.78%
Back Pain: 14 people, 77.78%
Cough: 13 people, 72.22%
Joint Pain: 13 people, 72.22%
Dyspnea Exertional: 13 people, 72.22%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 12 people, 66.67%
Hyperhidrosis (abnormally increased sweating): 12 people, 66.67%
Ecchymosis (a discoloration of the skin resulting from bleeding underneath): 12 people, 66.67%
Weight Fluctuation: 11 people, 61.11%
Drug Hypersensitivity: 11 people, 61.11%

What are the existing conditions these people have? *

Pain: 14 people, 77.78%
Sleep Disorder: 11 people, 61.11%
Sleep Apnea Syndrome: 11 people, 61.11%
Rickets (softening of bones): 11 people, 61.11%
Migraine (headache): 11 people, 61.11%
Hypokalemia (low potassium): 11 people, 61.11%
Headache (pain in head): 11 people, 61.11%
Allergic Rhinitis: 11 people, 61.11%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 16.67%
Cellulitis (infection under the skin): 3 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Dyazide and have Hyporeflexia?

- Check whether Hyporeflexia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dyazide:

Dyazide (11,506 reports)

Hyporeflexia treatments and more:

Hyporeflexia (3,443 reports)

How severe was Hyporeflexia and when was it recovered:

Hyporeflexia in Dyazide

Expand to all the drugs that have ingredients of hydrochlorothiazide; triamterene:

Hyporeflexia and drugs with ingredients of hydrochlorothiazide; triamterene

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dyazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyporeflexia:

Hyporeflexia (448 drugs)

Browse all the conditions that are associated with Hyporeflexia:

Hyporeflexia (593 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide; triamterene (the active ingredients of Dyazide) and Dyazide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.